These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 11859400)
1. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation. Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400 [TBL] [Abstract][Full Text] [Related]
2. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507 [TBL] [Abstract][Full Text] [Related]
3. Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis. Vusirikala M; Wolff SN; Stein RS; Brandt SJ; Morgan DS; Greer JP; Schuening FG; Dummer JS; Goodman SA Bone Marrow Transplant; 2001 Aug; 28(3):265-70. PubMed ID: 11535994 [TBL] [Abstract][Full Text] [Related]
4. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431 [TBL] [Abstract][Full Text] [Related]
8. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes. Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071 [TBL] [Abstract][Full Text] [Related]
9. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients. Fife KH; Warren TJ; Justus SE; Heitman CK; Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016 [TBL] [Abstract][Full Text] [Related]
10. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Kawaguchi K; Inamura H; Abe Y; Koshu H; Takashita E; Muraki Y; Matsuzaki Y; Nishimura H; Ishikawa H; Fukao A; Hongo S; Aoyagi M Laryngoscope; 2007 Jan; 117(1):147-56. PubMed ID: 17202945 [TBL] [Abstract][Full Text] [Related]
11. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M; N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423 [TBL] [Abstract][Full Text] [Related]
12. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts. Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Miserocchi E; Modorati G; Galli L; Rama P Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271 [TBL] [Abstract][Full Text] [Related]
14. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428 [TBL] [Abstract][Full Text] [Related]
15. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life. Handsfield HH; Warren T; Werner M; Phillips JA Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847 [TBL] [Abstract][Full Text] [Related]
16. A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation. Reischig T; Opatrny K; Bouda M; Treska V; Jindra P; Svecova M Transpl Int; 2002 Dec; 15(12):615-22. PubMed ID: 12478408 [TBL] [Abstract][Full Text] [Related]
17. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients. Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989 [TBL] [Abstract][Full Text] [Related]
18. Valacyclovir. New indication: for genital herpes, simpler administration. Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269 [TBL] [Abstract][Full Text] [Related]
19. Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia. Orlowski RZ; Mills SR; Hartley EE; Ye X; Piantadosi S; Ambinder RF; Gore SD; Miller CB Leuk Lymphoma; 2004 Nov; 45(11):2215-9. PubMed ID: 15512809 [TBL] [Abstract][Full Text] [Related]
20. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]